Joan Højgaard

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients

Nicolas M. Van Mieghem, G. Michael Deeb, Lars Søndergaard et al. · JAMA Cardiology · 2022 · 178 citations · Full text

Medicine, Cardiology, Surgery +13

Multimodal prediction of residual consciousness in the intensive care unit: the CONNECT-ME study

Moshgan Amiri, Patrick M. Fisher, Federico Raimondo et al. · Brain · 2022 · 82 citations · Full text

Medicine, Neuroscience, Neurocritical Care +16

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Thrombectomy assisted by carotid stenting in acute ischemic stroke management: benefits and harms

Henrik Steglich‐Arnholm, Markus Holtmannspötter, Daniel Kondziella et al. · Journal of Neurology · 2015 · 77 citations

Medicine, Neurosurgery, Surgery +14